CorMedix Inc. (CRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CRMD trades at $7.94 with a market cap of $620.55M and a P/E ratio of 3.42. CRMD moved +1.41% today. Year to date, CRMD is -34.95%; over the trailing twelve months it is -38.14%. Its 52-week range spans $5.60 to $17.43. Analyst consensus is strong buy with an average price target of $14.25. Rallies surfaces CRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CRMD recently traded at $7.94. Market cap is $620.55M. P/E ratio is 3.42. Revenue is $400.05M.
| Metric | Value |
|---|---|
| Price | $7.94 |
| Market Cap | $620.55M |
| P/E Ratio | 3.42 |
| EPS | $2.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.43 |
| 52-Week Low | $5.60 |
| Volume | 544 |
| Avg Volume | 0 |
| Revenue (TTM) | $400.05M |
| Net Income | $181.01M |
| Gross Margin | 85.83% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $311.71M | $163.06M | $2.25 |
| 2024 | $43.47M | $-17.93M | $-0.30 |
| 2023 | $0 | $-46.34M | $-0.91 |
| 2022 | $65.41K | $-29.70M | $-0.74 |
5 analysts cover CRMD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.25.